kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -75.35%2.26B | 31.29%8.01B | -81.36%1.91B | 143.46%35.02B | 31.62%9.54B | 153.40%9.16B | 22.99%6.1B | 810.08%10.22B | 142.45%14.38B | 25.52%7.25B |
Net profit before non-cash adjustment | 16.36%5.05B | -30.96%1.13B | -47.57%1.88B | 167.07%10.95B | -49.42%1.39B | 2,934.27%4.34B | -2.03%1.64B | 862.47%3.58B | 41.59%4.1B | 380.33%2.75B |
Total adjustment of non-cash items | -26.92%3.69B | -3.24%5.52B | 5.40%4.24B | 1.07%19.15B | -5.53%4.38B | -3.68%5.05B | 17.82%5.71B | -5.01%4.02B | 6.72%18.95B | -0.60%4.63B |
-Depreciation and amortization | 3.61%4.76B | 3.22%4.71B | 5.88%4.78B | 2.76%18.31B | 3.18%4.64B | 2.34%4.6B | 1.74%4.57B | 3.80%4.51B | 3.15%17.82B | 2.51%4.5B |
-Reversal of impairment losses recognized in profit and loss | --0 | ---2M | --90M | 775.00%1.47B | --172M | --74M | ---- | ---- | -72.37%168M | --0 |
-Disposal profit | -33.91%76M | -65.58%116M | -9.09%90M | 31.26%676M | -12.59%125M | 5.50%115M | 104.24%337M | 1.02%99M | 1.78%515M | -17.82%143M |
-Other non-cash items | -542.69%-1.15B | 264.22%693M | -21.98%-716M | -394.59%-1.31B | -9,216.67%-559M | -59.25%260M | -2,109.52%-422M | -180.86%-587M | 169.92%444M | -105.94%-6M |
Changes in working capital | -2,766.81%-6.48B | 208.25%1.35B | -260.73%-4.21B | 156.73%4.92B | 2,936.09%3.77B | 87.21%-226M | 20.05%-1.25B | 150.31%2.62B | 41.13%-8.67B | -106.35%-133M |
-Change in receivables | -659.94%-7.16B | 175.28%3.73B | -205.12%-1.91B | 185.59%1.78B | 420.05%3.64B | 377.22%1.28B | -206.49%-4.96B | 59.33%1.82B | 73.52%-2.08B | -134.56%-1.14B |
-Change in inventory | 18.16%1.74B | -101.10%-36M | 62.79%-505M | 125.99%1.19B | -347.08%-2.2B | 1,241.82%1.48B | 1,625.70%3.27B | 74.62%-1.36B | 68.49%-4.56B | 126.93%890M |
-Change in payables | 35.77%-2.47B | -250.77%-1.38B | -301.24%-1.78B | 136.21%1.04B | 2,468.33%3.08B | -83.43%-3.84B | -14.93%912M | 145.06%884M | -137.73%-2.86B | -95.48%120M |
-Changes in other current liabilities | 62.60%1.4B | -108.37%-971M | -101.02%-13M | 10.07%918M | -12,400.00%-750M | 26.99%861M | 41.82%-466M | 32.19%1.27B | --834M | 98.90%-6M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 28.11%319M | -7.14%13M | 22.48%316M | -5.60%556M | 20.69%35M | 0.81%249M | -17.65%14M | -12.84%258M | 11.98%589M | 107.14%29M |
Interest paid (cash flow from operating activities) | -145.31%-157M | 9.09%-40M | -61.29%-100M | -21.39%-210M | 21.57%-40M | 16.88%-64M | -1,200.00%-44M | -26.53%-62M | -73.00%-173M | -400.00%-51M |
Interest received (cash flow from operating activities) | 44.83%42M | 46.67%44M | 40.74%38M | 20.75%128M | 10.53%42M | 26.09%29M | 11.11%30M | 50.00%27M | 70.97%106M | 171.43%38M |
Tax refund paid | -48.37%-1.09B | -211.65%-321M | -78.60%-1.43B | 10.87%-1.67B | -288.89%-34M | 8.34%-736M | -5,050.00%-103M | 26.63%-799M | -55.04%-1.88B | 111.11%18M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%-1M |
Operating cash flow | -84.15%1.37B | 28.47%7.7B | -92.41%732M | 159.57%33.82B | 31.06%9.54B | 187.39%8.64B | 19.80%6B | 526.07%9.64B | 150.06%13.03B | 28.73%7.28B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -8.07%-3.2B | -157.46%-7.58B | 1.80%-6.12B | -24.37%-18.43B | -31.75%-6.29B | -25.57%-2.96B | 27.35%-2.94B | -71.55%-6.24B | 0.11%-14.82B | -29.46%-4.77B |
Net intangibles purchase and sale | 65.20%-79M | -128.92%-190M | -54.26%-199M | 33.30%-735M | -114.49%-296M | -23.37%-227M | 85.34%-83M | 39.72%-129M | 1.08%-1.1B | 60.00%-138M |
Net changes in other investments | -129.88%-216M | 67.11%-398M | -300.00%-10M | 767.50%267M | 3,645.00%749M | 1,821.43%723M | -24,300.00%-1.21B | 121.74%5M | -109.90%-40M | 25.00%20M |
Investing cash flow | 173.31%1.81B | -92.75%-8.17B | 0.42%-6.33B | -18.40%-18.9B | -19.30%-5.83B | 4.61%-2.47B | 8.15%-4.24B | -64.26%-6.36B | -2.68%-15.96B | -21.79%-4.89B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 99.74%-13M | -84,700.00%-3.39B | 99.99%-1M | -165.96%-13.01B | -105.71%-2M | -1,551.49%-5B | -100.00%-4M | -140.02%-8B | 314.23%19.73B | 1,850.00%35M |
Increase or decrease of lease financing | -8.30%-248M | -7.83%-179M | -29.03%-280M | -3.27%-789M | 6.84%-177M | -19.27%-229M | 13.54%-166M | -14.21%-217M | -2.41%-764M | 6.86%-190M |
Cash dividends paid | -75.23%-1.34B | -186.67%-43M | -200.79%-1.14B | -198.74%-1.18B | -188.89%-26M | -301.58%-763M | -87.50%-15M | -100.53%-379M | 69.09%-396M | 47.06%-9M |
Cash dividends for minorities | --0 | 89.42%-128M | -967.06%-907M | -3.19%-1.3B | --0 | --0 | -5.68%-1.21B | 22.73%-85M | -67.56%-1.26B | --0 |
Net other fund-raising expenses | 200.00%3M | -100.00%-2M | -50.00%-3M | 99.05%-3M | ---1M | --1M | ---1M | 99.37%-2M | -15,650.00%-315M | --0 |
Financing cash flow | 73.39%-1.6B | -168.19%-3.74B | 73.16%-2.33B | -195.79%-16.28B | -25.61%-206M | -775.18%-6B | -3.64%-1.4B | -145.25%-8.69B | 241.80%17B | 26.46%-164M |
Net cash flow | ||||||||||
Beginning cash position | -21.30%34.25B | -8.20%39.42B | -2.08%46.55B | 44.63%47.53B | -5.32%42.61B | -5.51%43.52B | -8.19%42.94B | 44.63%47.53B | -39.32%32.87B | 46.67%45.01B |
Current changes in cash | 798.30%1.58B | -1,258.95%-4.21B | -46.78%-7.93B | -109.67%-1.36B | 57.27%3.5B | 166.67%176M | 138.01%363M | -141.38%-5.4B | 163.03%14.07B | 57.01%2.23B |
Effect of exchange rate changes | 185.82%926M | -560.48%-967M | -0.98%805M | -37.73%373M | 43.00%429M | -37.63%-1.08B | -9.87%210M | -4.35%813M | -41.45%599M | -60.68%300M |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1M | 200.00%1M | ---- |
End cash Position | -13.75%36.75B | -21.30%34.25B | -8.20%39.42B | -2.08%46.55B | -2.08%46.55B | -5.32%42.61B | -5.51%43.52B | -8.19%42.94B | 44.63%47.53B | 44.63%47.53B |
Free cash flow | -135.53%-1.92B | -102.40%-71M | -271.35%-5.61B | 591.83%14.51B | 22.33%2.87B | 1,093.38%5.41B | 711.78%2.96B | 153.53%3.27B | 72.70%-2.95B | 46.32%2.35B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |